Drug Metabolism and Disposition: 13 (2)

March 01, 1985; Volume 13,Issue 2

You have access
Relationships among the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.
J G Wagner

Drug Metabolism and Disposition March 1985, 13 (2) 119-120;
You have access
Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice.
L J Fischer, M D Green and A W Harman

Drug Metabolism and Disposition March 1985, 13 (2) 121-126;
You have access
The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.
W M Awni and R J Sawchuk

Drug Metabolism and Disposition March 1985, 13 (2) 127-132;
You have access
The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
W M Awni and R J Sawchuk

Drug Metabolism and Disposition March 1985, 13 (2) 133-138;
You have access
Tracazolate metabolites in rat tissue.
F R Zuleski, K M Kirkland, M D Melgar and J O Malbica

Drug Metabolism and Disposition March 1985, 13 (2) 139-147;
You have access
Genetic differences in 2-aminofluorene pharmacokinetics between intact C57BL/6J and A/J mice.
T A Hultin and W W Weber

Drug Metabolism and Disposition March 1985, 13 (2) 148-150;
You have access
Mephenytoin metabolism in vitro by human liver.
M Jurima, T Inaba and W Kalow

Drug Metabolism and Disposition March 1985, 13 (2) 151-155;
You have access
The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
C G Meredith, A L Maldonado and K V Speeg

Drug Metabolism and Disposition March 1985, 13 (2) 156-162;
You have access
Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture.
P Wiebkin, J H Dees, J M Mathis and R A Prough

Drug Metabolism and Disposition March 1985, 13 (2) 163-168;
You have access
Evaluation of the role of free hydroxyl radicals in the cytochrome P-450-catalyzed oxidation of benzene and cyclohexanol.
L D Gorsky and M J Coon

Drug Metabolism and Disposition March 1985, 13 (2) 169-174;
You have access
Stereospecific in vivo N-methylation of nicotine in the guinea pig.
K C Cundy, M Sato and P A Crooks

Drug Metabolism and Disposition March 1985, 13 (2) 175-185;
You have access
Development of UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside in neonatal rats.
J B Watkins and C D Klaassen

Drug Metabolism and Disposition March 1985, 13 (2) 186-191;
You have access
Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
M J Reasor and M E Davis

Drug Metabolism and Disposition March 1985, 13 (2) 192-196;
You have access
Polyamine effects on cytochrome P-450- and flavin-containing monooxygenase-mediated oxidation of xenobiotics.
T G Osimitz and A P Kulkarni

Drug Metabolism and Disposition March 1985, 13 (2) 197-203;
You have access
Quantitative account of propranolol metabolism in urine of normal man.
T Walle, U K Walle and L S Olanoff

Drug Metabolism and Disposition March 1985, 13 (2) 204-209;
You have access
Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue.
F Farinati, Z Zhou, J Bellah, C S Lieber and A J Garro

Drug Metabolism and Disposition March 1985, 13 (2) 210-214;
You have access
Studies on the beta-oxidative metabolism of delta 1- and delta 6-tetrahydrocannabinol in the mouse. The in vivo biotransformation of metabolites oxidized in the side chain.
D J Harvey and J T Leuschner

Drug Metabolism and Disposition March 1985, 13 (2) 215-219;
You have access
Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
D Godeneche, J C Madelmont, M F Moreau, J Duprat, J L Chabard, R Plagne and G Meyniel

Drug Metabolism and Disposition March 1985, 13 (2) 220-226;
You have access
Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
A Bortolotti, L Jiritano and M Bonati

Drug Metabolism and Disposition March 1985, 13 (2) 227-231;
You have access
Glucuronidation of morphine and six beta 2-sympathomimetics in isolated rat intestinal epithelial cells.
A S Koster, A C Frankhuijzen-Sierevogel and J Noordhoek

Drug Metabolism and Disposition March 1985, 13 (2) 232-238;
You have access
Species differences in the metabolism of suprofen in laboratory animals and man.
Y Mori, N Kuroda, Y Sakai, F Yokoya, K Toyoshi and S Baba

Drug Metabolism and Disposition March 1985, 13 (2) 239-245;
You have access
In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
T Suzuki, Y Hashimura and S Takeyama

Drug Metabolism and Disposition March 1985, 13 (2) 246-254;
You have access
The in vitro metabolism of hydralazine.
A J Streeter and J A Timbrell

Drug Metabolism and Disposition March 1985, 13 (2) 255-259;
You have access
Pharmacokinetic analysis of potassium cyanate in mice using whole blood and expired air.
J D Johnson, P R Mayer and G E Isom

Drug Metabolism and Disposition March 1985, 13 (2) 260-262;
You have access
n-Butylglycidyl ether: the formation of a novel metabolite of an epoxide.
C V Eadsforth, C J Logan, J A Page and P D Regan

Drug Metabolism and Disposition March 1985, 13 (2) 263-264;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals